WASHINGTON — At least nine women have died of a rare blood cancer and the U.S. Food and Drug Administration is blaming the deaths on breast implants.
The agency announced that as of the beginning of February, it has received 359 reports of a rare type on non-Hodgkin’s lymphoma called anaplastic large cell lymphoma.
Those reports were associated with breast implants. People with implants have a 65 times higher risk of developing the disease.
Textured implants seemed to produce more results of ALCL than implants with smooth surfaces.
The results concerning the link between textured implants being more likely to cause the disease have not been conclusively proven.
The FDA first announced a possible link between breast cancer and ALCL in 2011.
It is estimated the prevalence of ALCL in people with textured implants falls at roughly 33 per 1 million.
According to the American Society of Plastic Surgeons, about 290,000 people opted for breast augmentation using implants in the U.S. in 2016.